Gut microbiota, host organism, and diet trialogue in diabetes and obesity

Frontiers in Nutrition

Volumn 6, Issue , 2019, Pages

  Lazar, Veronica ^a   Ditu, Lia Mara ^a   Pircalabioru, Gratiela G ^a   Picu, Ariana ^a,b   Petcu, Laura ^a,b   Cucu, Natalia ^a,c   Chifiriuc, Mariana Carmen ^a  

^a UNIVERSITY OF BUCHAREST   (Romania)

^b National Institute for Diabetes   (Romania)

^c FUNDENI CLINICAL INSTITUTE   (Romania)

Author keywords

Diabetes; Diet; Gut physiology; Microbiome; Obesity; Prebiotics; Probiotics

Indexed keywords

EID: 85067828804     PISSN: None     EISSN: 2296861X     Source Type: Journal    
DOI: 10.3389/fnut.2019.00021     Document Type: Review

References (202)

1. Sekirov, I, Russell, SL, Antunes, LC, Finlay, BB. Gut microbiota in health and disease. Physiol Rev. (2010) 90:859–904. 10.1152/physrev.00045.2009, 20664075.
2. Sonnenburg, JL, Bäckhed, F. Diet–microbiota interactions as moderators of human metabolism. Nature. (2016) 535:56–64. 10.1038/nature18846, 27383980.
3. Clemente, JC, Ursell, LK, Parfrey, LW, Knight, R. The impact of the gut microbiota on human health: an integrative view. Cell. (2012) 148:1258–70. 10.1016/j.cell.2012.01.035, 22424233.
4. Qin, J, Li, R, Raes, J, Arumugam, M, Burgdorf, KS, Manichanh, C,. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. (2010) 464:59–65. 10.1038/nature08821, 20203603.
5. The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature. (2012) 486:207–14. 10.1038/nature11234.
6. Frank, DN, St Amand, AL, Feldman, RA, Boedeker, EC, Harpaz, N, Pace, NR. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci USA. (2007) 104:13780–5. 10.1073/pnas.0706625104, 17699621.
7. Hugon, P, Dufour, JC, Colson, P, Fournier, PE, Sallah, K, Raoult, D. A comprehensive repertoire of prokaryotic species identified in human beings. Lancet Infect Dis. (2015) 15:1211–9. 10.1016/S1473-3099(15)00293-5, 26311042.
8. Mikelsaar, M, Lazar, V, Onderdonk, AB, Donelli, G. Do probiotic preparations for humans really have efficacy?, Microbial Ecol Health Dis. (2011) 22:10128. 10.3402/mehd.v22i0.10128.
9. Arumugam, M, Raes, J, Pelletier, E, Le Paslier, D, Yamada, T, Mende, DR,. Enterotypes of the human gut microbiome. Nature. (2011) 473:174–80. 10.1038/nature09944, 21508958.
10. Zhernakova, A, Kurilshikov, A, Bonder, MJ, Tigchelaar, EF, Schirmer, M, Vatanen, T,. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity. Science. (2016) 352:565–9. 10.1126/science.aad3369, 27126040.
11. Jandhyala, SM, Talukdar, R, Subramanyam, C, Vuyyuru, H, Sasikala, M, Reddy, DN. Role of the normal gut microbiota. World J Gastroenterol. (2015) 21:8787–803. 10.3748/wjg.v21.i29.8787, 26269668.
12. Maurice, CF, Haiser, HJ, Turnbaugh, PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell. (2013) 152:39–50. 10.1016/j.cell.2012.10.052, 23332745.
13. Sharon, G, Garg, N, Debelius, J, Knight, R, Dorrestein, PC, Mazmanian, SK. Specialized metabolites from the microbiome in health and disease. Cell Metab. (2014) 20:719–30. 10.1016/j.cmet.2014.10.016, 25440054.
14. Vajro, P, Paolella, G, Fasano, A. Microbiota and gut-liver axis: their influences on obesity and obesity-related liver disease. J Pedriatic Gastroenterol Nutr. (2013) 56:461–46. 10.1097/MPG.0b013e318284abb5, 23287807.
15. Boerner, BP, Sarvetnick, NE. Type 1 diabetes: role of intestinal microbiome in humans and mice. Ann NY Acad Sci. (2011) 1243:103–18. 10.1111/j.1749-6632.2011.06340.x, 22211896.
16. Daïen, CI, Pinget, GV, Tan, JK, Macia, L. Detrimental impact of microbiota-accessible carbohydrate-deprived diet on gut and immune homeostasis: an overview. Front Immunol. (2017) 12:548. 10.3389/fimmu.2017.00548.
17. Bonder, MJ, Kurilshikov, A, Tigchelaar, EF, Mujagic, Z, Imhann, F, Vila, AV,. The effect of host genetics on the gut microbiome. Nat Genet. (2016) 48:1407–12. 10.1038/ng.3663, 27694959.
18. Ohira, H, Tsutsui, W, Fujioka, Y. Are short chain fatty acids in gut microbiota defensive players for inflammation and atherosclerosis?, J Atheroscler Thromb. (2017) 24:660–72. 10.5551/jat.RV17006, 28552897.
19. Wang, LL, Guo, HH, Huang, S, Feng, CL, Han, YX, Jiang, JD. Comprehensive evaluation of SCFA production in the intestinal bacteria regulated by berberine using gas-chromatography combined with polymerase chain reaction. J Chromatogr B Analyt Technol Biomed Life Sci. (2017) 1057:70–80. 10.1016/j.jchromb.2017.05.004, 28505492.
20. Albenberg, LG, Wu, GD. Diet and the intestinal microbiome: associations, functions, and implications for health and disease. Gastroenterology. (2014) 146:1564–72. 10.1053/j.gastro.2014.01.058, 24503132.
21. Furusawa, Y, Obata, Y, Fukuda, S, Endo, TA, Nakato, G, Takahashi, D,. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. (2013). 504:446–50. 10.1038/nature12721, 24226770.
22. Kim, MH, Kang, SG, Park, JH, Yanagisawa, M, Kim, CH. Short-chain fatty acids activate GPR41 and GPR43 on intestinal epithelial cells to promote inflammatory responses in mice. Gastroenterology. (2013) 145:396–406. 10.1053/j.gastro.2013.04.056, 23665276.
23. Heianza, Y, Qi, L. Gene-diet interaction and precision nutrition in obesity. Int J Mol Sci. (2017) 18:E787. 10.3390/ijms18040787, 28387720.
24. Chen, ML, Yi, L, Zhang, Y, Zhou, X, Ran, L, Yang, J,. Resveratrol attenuates Trimethylamine-N-Oxide (TMAO)-induced atherosclerosis by regulating TMAO synthesis and bile acid metabolism via remodeling of the gut microbiota. mBio. (2016) 7:e00210–5. 10.1128/mBio.02210-15, 27048804.
25. Dimitrov, D, Thiele, I, Ferguson, LR. Editorial: the human gutome: nutrigenomics of host-microbiome interactions. Front Genet. (2016) 7:158. 10.3389/fgene.2016.00158, 27656194.
26. Craig, SA. Betaine in human nutrition. Am J Clin Nutr. (2004) 80:539–49. 10.1093/ajcn/80.3.539, 15321791.
27. Levy, M, Thaiss, CA, Elinav, E. Metabolites: messengers between the microbiota and the immune system. Genes Dev. (2016) 30:1589–97. 10.1101/gad.284091.116, 27474437.
28. Collins, SM, Surette, M, Bercik, P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol. (2012) 10:735–42. 10.1038/nrmicro2876, 23000955.
29. Heiss, CN, Olofsson, LE. Gut microbiota-dependent modulation of energy metabolism. J Innate Immun. (2018) 10:163–71. 10.1159/000481519, 29131106.
30. Shenderov, BA. Gut indigenous microbiota and epigenetics. Microb Ecol Health Dis. (2012) 23:17195. 10.3402/mehd.v23i0.17195, 23990811.
31. Bonder, MJ, Tigchelaar, EF, Cai, X, Trynka, G, Cenit, MC, Hrdlickova, B,. The influence of a short-term gluten-free diet on the human gut microbiome. Genome Med. (2016) 8:45. 10.1186/s13073-016-0295-y, 27102333.
32. Buitrago-Lopez, A, Sanderson, J, Johnson, L, Warnakula, S, Wood, A, Di Angelantonio, E,. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. (2011) 343:d448. 10.1136/bmj.d4488, 21875885.
33. Burcelin, R. The hologenome theory of metabolic diversity. Mol Metab. (2016) 5:771–81. 10.1016/j.molmet.2016.05.016.
34. Zilber-Rosenberg, I, Rosenberg, E. Role of microorganisms in the evolution of animals and plants: the hologenome theory of evolution. FEMS Microbiol Rev. (2008) 32:723–35. 10.1111/j.1574-6976.2008.00123.x, 18549407.
35. Qin, Y, Wade, PA. Crosstalk between the microbiome and epigenome: messages from bugs. J Biochem. (2018) 163:105–12. 10.1093/jb/mvx080, 29161429.
36. Kumar, P, Gogulamudi, VR, Peryasamy, R, Raghavaraju, G, Subramania, U, Pandey, KN. Inhibition of HDAC enhances STAT acetylation, blocks NF-KappaB, and suppresses the renal inflammation and fibrosis in Npr1 haplotype male mice. Am. J. Physiol. Renal Physiol. (2017) 313:F781–95. 10.1152/ajprenal.00166.2017, 28566502.
37. World Health Organisation. Global Report on Diabetes, World Health Organisation (2016).
38. International Diabetes Federation (2017). IDF Diabetes Atlas, 8th Edn. Available online at: http://diabetesatlas.org/resources/2017-atlas.html.
39. Ogurtsova, K, Da Rocha Fernandes, JD, Huang, Y, Linnenkamp, U, Guariguata, L, Cho, NH,. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. (2017) 128:40–50. 10.1016/j.diabres.2017.03.024, 28437734.
40. Phillips, CM. Nutrigenetics and metabolic disease: current status and implications for personalised nutrition. Nutrients. (2013) 5:32–57. 10.3390/nu5010032, 23306188.
41. Paneni, F, Costantino, S, Cosentino, F. Insulin resistance, diabetes, and cardiovascular risk. Curr Atheroscler Rep. (2014) 16:419. 10.1007/s11883-014-0419-z, 24781596.
42. Doros, R, Lixandru, D, Petcu, L, Tudosoiu, J, Mitu, M, Picu, A,. Resting metabolic rate in type 2 diabetes–accuracy of predictive equations. Rom Biotechnol Lett. (2016) 22:12033–8.
43. Trayhurn, P, Bing, C, Wood, IS. Adipose tissue and adipokines—energy regulation from the human perspective. J Nutr. (2006) 136:1935S−9S. 10.1093/jn/136.7.1935S, 16772463.
44. Zhang, Y, Proenca, R, Maffei, M, Barone, M, Leopold, L, Friedman, JM. Positional cloning of the mouse obese gene and its human homolog. Nature. (1994) 372:425–32. 10.1038/372425a0.
45. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications: Report of a WHO Consultation. Part 1, Diagnosis and Classification of Diabetes Mellitus., Geneva (1999).
46. Guzik, TJ, Cosentino, F. Epigenetics and immunometabolism in diabetes and aging. Antioxid Redox Signal. (2018) 29:253–74. 10.1089/ars.2017.7299, 28891325.
47. Ionescu-Tîrgovişte, C. Treatise on Diabetes Paulescu., Bucharest: Academy (2004).
48. Turer, AT, Scherer, PE. Adiponectin: mechanistic insights and clinical implications. Diabetologia. (2012) 55:2319–26. 10.1007/s00125-012-2598-x, 22688349.
49. Weisberg, SP, Hunter, D, Huber, R, Lemieux, J, Slaymaker, S, Vaddi, K,. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest. (2006) 116:115–20. 10.1172/JCI24335, 16341265.
50. El Homsi, M, Ducroc, R, Claustre, J, Jourdan, G, Gertler, A, Estienne, M,. Leptin modulates the expression of secreted and membrane-associated mucins in colonic epithelial cells by targeting PKC, PI3K, and MAPK pathways. Am J Physiol Gastrointest Liver Physiol. (2007). 293:G365–73. 10.1152/ajpgi.00091.2007, 17495032.
51. Wellen, KE, Hotamisligil, GS. Inflammation, stress and diabetes. J Clin Invest. (2005) 115:1111–9. 10.1172/JCI25102, 15864338.
52. Ceriello, A, Motz, E. Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease?, Arterioscler Thromb Vasc Biol. (2004) 24:816–23. 10.1161/01.ATV.0000122852.22604.78, 14976002.
53. Kunisaki, M, Bursell, SE, Clermont, AC, Ishii, H, Ballas, LM, Jirousek, MR,. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. Am J Physiol. (1995) 269:E239–46. 10.1152/ajpendo.1995.269.2.E239, 7653541.
54. King, GL, Brownlee, M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am. (1996) 25:255–70. 10.1016/S0889-8529(05)70324-8, 8799700.
55. Jones, DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol. (2008) 295:C849–68. 10.1152/ajpcell.00283.2008, 18684987.
56. Timofte, D, Toarba, C, Hogas, S, Covic, A, Ciobica, A, Chirita, R,. The relevance of oxidative stress status in type 2 diabetes and the chronic consumption of alcohol. Rom Biotechnol Lett. (2016) 21:11246–53.
57. Lazo-de-la-Vega-Monroy, ML, Fernandez-Mejia, C. Oxidative stress in diabetes mellitus and the role of vitamins with antioxidant actions. In: Morales-Gonzalez, JA, editor. Oxidative Stress and Chronic Degenerative Diseases, London: IntechOpen (2013), 209–232. 10.5772/51788.
58. Albenberg, L, Esipova, TV, Judge, CP, Bittinger, K, Chen, J, Laughlin, A,. Correlation between intraluminal oxygen gradient and radial partitioning of intestinal microbiota. Gastroenterology. (2014) 147:1055–63.e8. 10.1053/j.gastro.2014.07.020, 25046162.
59. Winter, SE, Lopez, CA, Bäumler, AJ. The dynamics of gut-associated microbial communities during inflammation. EMBO Rep. (2013) 14:319–27. 10.1038/embor.2013.27, 23478337.
60. Lopez, CA, Miller, BM, Rivera-Chavez, F, Velasquez, EM, Byndloss, MX, Chávez-Arroyo, A,. Virulence factors enhance citrobacter rodentium expansion through aerobic respiration. Science. (2016) 353:1249–53. 10.1126/science.aag3042, 27634526.
61. Guinane, CM, Cotter, P. Role of the gut microbiota in health and chronic gastrointestinal disease: understanding a hidden metabolic organ. Therap Adv Gastroenterol. (2013) 6:295–308. 10.1177/1756283X13482996, 23814609.
62. Bischoff, SC, Barbara, G, Buurman, W, Ockhuizen, T, Schulzke, JD, Serino, M,. Intestinal permeability – a new target for disease prevention and therapy. BMC Gastroenterol. (2014) 18:14189. 10.1186/s12876-014-0189-7.
63. Tolhurst, G, Heffron, H, Lam, YS, Parker, HE, Habib, AM, Diakogiannaki, E,. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. (2012) 61:364–71. 10.2337/db11-1019, 22190648.
64. Bäckhed, F, Ding, H, Wang, T, Hooper, LV, Koh, GY, Nagy, A,. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA. (2004) 101:15718–23. 10.1073/pnas.0407076101, 15505215.
65. Dumas, ME, Barton, RH, Toye, A, Cloarec, O, Blancher, C, Rothwell, A,. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci USA. (2006) 103:12511–6. 10.1073/pnas.0601056103, 16895997.
66. Hattori, M, Taylor, TD. The human intestinal microbiome: a new frontier of human biology. DNA Res. (2009) 16:1–12. 10.1093/dnares/dsn033, 19147530.
67. Oldstone, MB. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. (1988) 239:500–2. 10.1126/science.239.4839.500, 3277269.
68. King, C, Sarvetnick, N. The incidence of type-1 diabetes in NOD mice is modulated by restricted flora not germ-free conditions. PLoS ONE. (2011) 6:e17049. 10.1371/journal.pone.0017049.
69. Brugman, S, Klatter, FA, Visser, JT, Wildeboer-Veloo, AC, Harmsen, HJ, Rozing, J,. Antibiotic treatment partially protects against type 1 diabetes in the bio-breeding diabetes-prone rat. Is the gut flora involved in the development of type 1 diabetes?, Diabetologia. (2006) 49:2105–8. 10.1007/s00125-006-0334-0, 16816951.
70. Patterson, E, Marques, TM, O'Sullivan, O, Fitzgerald, P, Fitzgerald, GF, Cotter, PD,. Streptozotocin-induced type-1-diabetes disease onset in sprague-dawley rats is associated with an altered intestinal microbiota composition and decreased diversity. Microbiology. (2015) 161:182–93. 10.1099/mic.0.082610-0, 25370749.
71. Neu, J, Reverte, CM, Mackey, AD, Liboni, K, Tuhacek-Tenace, LM, Hatch, M,. Changes in intestinal morphology and permeability in the biobreeding rat before the onset of type 1 diabetes. J Pediatr Gastroenterol Nutr. (2005) 40:589–95. 15861021.
72. Watts, T, Berti, I, Sapone, A, Gerarduzzi, T, Not, T, Zielke, R,. Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats. Proc Natl Acad Sci USA. (2005) 102:2916–21. 10.1073/pnas.0500178102, 15710870.
73. Valladares, R, Sankar, D, Li, N, Lai, KK, Abdelgeliel, AS, Gonzalez, CF,. Lactobacillus johnsonii N6. 2mitigates the development of type 1 diabetes in BB-DP rats. PLoS ONE. (2010) 5:e10507. 10.1371/journal.pone.0010507, 20463897.
74. Wen, L, Ley, RE, Volchkov, PY, Stranges, PB, Avanesyan, L, Stonebraker, AC,. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature. (2008) 455:1109–13. 10.1038/nature07336, 18806780.
75. Lagier, J, Armougom, F, Million, M, Hugon, P, Pagnier, I, Robert, C,. Microbial culturomics: paradigm shift in the human gut microbiome study. Clin Microbiol Infect. (2012) 18:1185–93. 10.1111/1469-0691.12023, 23033984.
76. Vaarala, O. Gut microbiota and type 1 diabetes. Rev Diabet Stud. (2012) 9:251–9. 10.1900/RDS.2012.9.251, 23804264.
77. Brown, CT, Davis-Richardson, AG, Giongo, A, Gano, KA, Crabb, DB, Mukherjee, N,. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS ONE. (2011) 6:e25792. 10.1371/journal.pone.0025792, 22043294.
78. Ley, RE, Bäckhed, F, Turnbaugh, P, Lozupone, CA, Knight, RD, Gordon, JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA. (2005) 102:11070–5. 10.1073/pnas.0504978102, 16033867.
79. Qin, J, Li, Y, Cai, Z, Li, S, Zhu, J, Zhang, F,. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. (2012) 490:55–60. 10.1038/nature11450, 23023125.
80. De Goffau, MC, Luopajärvi, K, Knip, M, Ilonen, J, Ruohtula, T, Härkönen, T,. Fecal microbiota composition differs between children with β-cell autoimmunity and those without. Diabetes. (2013) 62:1238–44. 10.2337/db12-0526, 23274889.
81. Murri, M, Leiva, I, Gomez-Zumaquero, JM, Tinahones, F, Cardona, F, Soriguer, F,. Gut microbiota in children with type 1 diabetes differs from that in healthy children: a case-control study. BMC Med. (2013) 11:46. 10.1186/1741-7015-11-46, 23433344.
82. Kostic, AD, Gevers, D, Siljander, H, Vatanen, T, Hyötyläinen, T, Hämäläinen, AM,. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microb. (2015) 17:260–73. 10.1016/j.chom.2015.01.001, 25662751.
83. De Groot, PF, Belzer, C, Aydin, Ö, Levin, E, Levels, JH, Aalvink, S,. Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study. PLoS ONE. (2017) 12:e0188475. 10.1371/journal.pone.0188475, 29211757.
84. Larsen, N, Vogensen, FK, van den Berg, FW, Nielsen, DS, Andreasen, AS, Pedersen, BK,. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE. (2010) 5:e9085. 10.1371/journal.pone.0009085, 20140211.
85. Suceveanu, AI, Pantea Stoian, A, Parepa, RI, Voinea, C, Hainarosie, R, Manuc, D,. Gut microbiota patterns in obese and type 2 diabetes. (T2D) patients from romanian black sea coast region. Rev Chim. (2018) 69:2260–7.
86. Chelariu, M, Grosu, M, Gheorghe, I, Pircalabioru, GG, Picu, A, Petcu, L,. Host metabolic syndrome can disrupt the intestinal microbiota and promote the acquisition of resistance and virulence genes in enterobacteriaceae stains. Rom BiotechnolLett. (2017) 22:12643–50.
87. Fei, N, Zhao, L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. (2013) 7:880–4. 10.1038/ismej.2012.153, 23235292.
88. de La Serre, CB, Ellis, CL, Lee, J, Hartman, AL, Rutledge, JC, Raybould, HE. Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. Am J Physiol Gastrointest Liver Physiol. (2010) 299:G440–8. 10.1152/ajpgi.00098.2010, 20508158.
89. Festi, D, Schiumerini, R, Eusebi, LH, Marasco, G, Taddia, M, Colecchia, A. Gut microbiota and metabolic syndrome.World J Gastroenterol. (2014) 20:16079–94. 10.3748/wjg.v20.i43.16079, 25473159.
90. Amar, J, Chabo, C, Waget, A, Klopp, P, Vachoux, C, Bermúdez-Humarán, LG,. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. EMBO Mol Med. (2011) 3:559–72. 10.1002/emmm.201100159, 21735552.
91. Caricilli, A, Saad, M. The role of gut microbiota on insulin resistance. Nutrients. (2013) 5:829–51. 10.3390/nu5030829, 23482058.
92. König, J, Wells, J, Cani, PD, García-Ródenas, CL, MacDonald, T, Mercenier, A,. Human intestinal barrier function in health and disease. Clin Transl Gastroenterol. (2016) 7:e196. 10.1038/ctg.2016.54, 27763627.
93. Furet, JP, Kong, LC, Tap, J, Poitou, C, Basdevant, A, Bouillot, JL,. Differential adaptation of human gut microbiota to bariatric surgery-induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. (2010) 59:3049–57. 10.2337/db10-0253, 20876719.
94. Kootte, RS, Levin, E, Salojärvi, J, Smits, LP, Hartstra, AV, Udayappan, SD,. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. (2017) 26:611–9.e6. 10.1016/j.cmet.2017.09.008, 28978426.
95. Singh, RK, Chang, HW, Yan, D, Lee, KM, Ucmak, D, Wong, K,. Influence of diet on the gut microbiome and implications for human health. J Transl Med. (2017) 15:73. 10.1186/s12967-017-1175-y, 28388917.
96. Sanz, Y. Effects of a gluten free diet on gut microbiota and immune function in healthy adult humans. Gut Microbes. (2010) 1:135–7. 10.4161/gmic.1.3.11868, 21327021.
97. de Vrese, M, Schrezenmeir, J. Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol. (2008) 111:1–66. 10.1007/10_2008_097, 18461293.
98. Cotillard, A, Kennedy, SP, Kong, LC, Prifti, E, Pons, N, Le Chatelier, E,. Dietary intervention impact on gut microbial gene richness. Nature. (2013) 500:585–8. 10.1038/nature12480, 23985875.
99. Carvalho-Wells, AL, Helmolz, K, Nodet, C, Molzer, C, Leonard, C, McKevith, B,. Determination of the in vivo prebiotic potential of a maizebased whole grain breakfast cereal: a human feeding study. Br J Nutr. (2010) 104:1353–6. 10.1017/S0007114510002084, 20487589.
100. Costabile, A, Klinder, A, Fava, F, Napolitano, A, Fogliano, V, Leonard, C,. Whole-grain wheat breakfast cereal has a prebiotic effect on the human gut microbiota: a double-blind, placebo-controlled, crossover study. Br J Nutr. (2008) 99:110–20. 10.1017/S0007114507793923, 17761020.
101. Wu, GD, Compher, C, Chen, EZ, Smith, SA, Shah, RD, Bittinger, K,. Comparative metabolomics in vegans and omnivores reveal constraints on diet-dependent Gut microbiota metabolite production. Gut. (2016) 65:63–72. 10.1136/gutjnl-2014-308209, 25431456.
102. Lopez-Legarrea, P, Fuller, NR, Zulet, MA, Martinez, JA, Caterson, ID. The influence of mediterranean, carbohydrate and high protein diets on gut microbiota composition in the treatment of obesity and associated inflammatory state. Asia Pac J Clin Nutr. (2014) 23:360–8. 10.6133/apjcn.2014.23.3.16, 25164445.
103. Villegas, R, Shu, XO, Gao, YT, Yang, G, Elasy, T, Li, H,. Vegetable but not fruit consumption reduces the risk of type 2 diabetes in Chinese women. J Nutr. (2008) 138:574–80. 10.1093/jn/138.3.574.
104. Hentges, DJ, Maier, BR, Burton, GC, Flynn, MA, Tsutakawa, RK. Effect of a high-beef diet on the fecal bacterial flora of humans. Cancer Res. (1977) 37:568–71. 832279.
105. David, LA, Maurice, CF, Carmody, RN, Gootenberg, DB, Button, JE, Wolfe, BE,. Diet rapidly and reproducibly alters the human gut microbiome. Nature. (2014) 505:559–63. 10.1038/nature12820, 24336217.
106. Lecomte, V, Kaakoush, NO, Maloney, CA, Raipuria, M, Huinao, KD, Mitchell, HM,. Changes in gut microbiota in rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS ONE. (2015) 10:e0126931. 10.1371/journal.pone.0126931, 25992554.
107. Devkota, S, Wang, Y, Musch, MW, Leone, V, Fehlner-Peach, H, Nadimpalli, A,. Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice. Nature. (2013) 487:104–8. 10.1038/nature11225, 22722865.
108. Prieto, I, Hidalgo, M, Segarra, AB, Martínez-Rodríguez, AM, Cobo, A, Ramírez, M,. Influence of a diet enriched with virgin olive oil or butter on mouse gut microbiota and its correlation to physiological and biochemical parameters related to metabolic syndrome. PLoS ONE. (2018) 13:e0190368. 10.1371/journal.pone.0190368, 29293629.
109. Wu, GD, Chen, J, Hoffmann, C, Bittinger, K, Chen, YY, Keilbaugh, SA,. Linking long-term dietary patterns with gut microbial enterotypes. Science. (2011) 334:105–8. 10.1126/science.1208344, 21885731.
110. Serino, M, Luche, E, Gres, S, Baylac, A, Bergé, M, Cenac, C,. Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota. Gut. (2012) 61:543–53. 10.1136/gutjnl-2011-301012, 22110050.
111. Caesar, R, Tremaroli, V, Kovatcheva-Datchary, P, Cani, PD, Bäckhed, F. Crosstalk between gut microbiota and dietary lipids aggravates WAT inflammation through TLR signaling. Cell Metab. (2015) 22:658–68. 10.1016/j.cmet.2015.07.026, 26321659.
112. Bai, Y, Sun, Q. Macrophage recruitment in obese adipose tissue. Obes Rev. (2015) 16:127–36. 10.1111/obr.12242, 25586506.
113. Jin, C, Flavell, RA. Innate sensors of pathogen and stress: linking inflammation to obesity. J Allergy Clin Immunol. (2013) 132:287–94. 10.1016/j.jaci.2013.06.022, 23905917.
114. Shi, H, Kokoeva, MV, Inouye, K, Tzameli, I, Yin, H, Flier, JS. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. (2006) 116:3015–25. 10.1172/JCI28898, 17053832.
115. Ivanov, II, Atarashi, K, Manel, N, Brodie, EL, Shima, T, Karaoz, U,. Induction of intestinal Th17 Cells by segmented filamentous bacteria. Cell. (2009) 139:485–98. 10.1016/j.cell.2009.09.033, 19836068.
116. Ramos-Romero, S, Hereu, M, Atienza, L, Casas, J, Jáuregui, O, Amézqueta, S,. Mechanistically different effects of fat and sugar on insulin resistance, hypertension and gut microbiota in rats. Am J Physiol Endocrinol Metab. (2018) 314:E552–63. 10.1152/ajpendo.00323.2017, 29351480.
117. Levine, ME, Suarez, JA, Brandhorst, S, Balasubramanian, P, Cheng, CW, Madia, F,. Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population. Cell Metab. (2014) 19:407–17. 10.1016/j.cmet.2014.02.006.
118. Bäckhed, F, Manchester, JK, Semenkovich, CF, Gordon, JI. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci USA. (2007) 104:979–84. 10.1073/pnas.0605374104, 17210919.
119. Seidell, JC. Dietary fat and obesity: an epidemiologic perspective. Am J Clin Nutr. (1998) 67:546S−50S. 10.1093/ajcn/67.3.546S, 9497168.
120. Bărbulescu, ID, Marinescu, SI, Begea, M, Teodorescu, RI. Reducing sugar in food as an option for lowering the risk of diabetes. Rom Biotechnol Lett. (2016) 21:11263–71.
121. Eid, N, Enani, S, Walton, G, Corona, G, Costabile, A, Gibson, G,. The impact of date palm fruits and their component polyphenols, on gut microbial ecology, bacterial metabolites and colon cancer cell proliferation. J Nutr Sci. (2014) 3:e46. 10.1017/jns.2014.16, 26101614.
122. Francavilla, R, Calasso, M, Calace, L, Siragusa, S, Ndagijimana, M, Vernocchi, P,. Effect of lactose on gut microbiota and metabolome of infants with Cow's milk allergy. Pediatr Allergy Immunol. (2012) 23:420–7. 10.1111/j.1399-3038.2012.01286.x, 22435727.
123. Nseir, W, Nassar, F, Assy, N. Soft drinks consumption and nonalcoholic fatty liver disease. World J Gastroenterol. (2010) 16:2579–88. 10.3748/wjg.v16.i21.2579, 20518077.
124. Amin, TT, Al-Sultan, AI, Ali, A. Overweight and obesity and their association with dietary habits, and sociodemographic characteristics among male primary school children in Al-Hassa, kingdom of Saudi Arabia. Indian J Community Med. (2008) 33:172–81. 10.4103/0970-0218.42058, 19876479.
125. Ludwig, DS, Peterson, KE, Gortmaker, SL. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet. (2001) 357:505–8. 10.1016/S0140-6736(00)04041-1, 11229668.
126. Suez, J, Korem, T, Zeevi, D, Zilberman-Schapira, G, Thaiss, CA, Maza, O,. Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature. (2014) 514:181–6. 10.1038/nature13793, 25231862.
127. Machiels, K, Joossens, M, Sabino, J, De Preter, V, Arijs, I, Eeckhaut, V,. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. (2014) 63:1275–83. 10.1136/gutjnl-2013-304833, 24021287.
128. Falony, G, Joossens, M, Vieira-Silva, S, Wang, J, Darzi, Y, Faust, K,. Population-level analysis of gut microbiome variation. Science. (2016) 6285:560–4. 10.1126/science.aad3503.
129. Kim, Y, Keogh, JB, Clifton, PM. Polyphenols and glycemic control. Nutrients. (2016) 8:17. 10.3390/nu8010017, 26742071.
130. Queipo-Ortuno, MI, Boto-Ordonez, M, Murri, M, Gomez-Zumaquero, JM, Clemente-Postigo, M, Estruch, R,. Influence of red wine polyphenols and ethanol on the gut microbiota ecology and biochemical biomarkers. Am J Clin Nutr. (2012) 95:1323–34. 10.3945/ajcn.111.027847, 22552027.
131. Hooper, L, Kay, C, Abdelhamid, A, Kroon, PA, Cohn, JS, Rimm, EB,. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. (2012) 95:740–51. 10.3945/ajcn.111.023457, 22301923.
132. Almoosawi, S, Tsang, C, Ostertag, LM, Fyfe, L, Dujaili, EA. Differential effect of polyphenol-rich dark chocolate on biomarkers of glucose metabolism and cardiovascular risk factors in healthy, overweight and obese subjects: a randomized clinical trial. Food Funct. (2012) 3:1035–43. 10.1039/c2fo30060e, 22796902.
133. Davison, K, Coates, AM, Buckley, JD, Howe, PR. Effect of Cocoa Flavanols and exercise on cardiometabolic risk factors in overweight and obese subjects. Int J Obes. (2008) 32:1289–96. 10.1038/ijo.2008.66, 18504447.
134. Rostami, A, Khalili, M, Haghighat, N, Eghtesadi, S, Shidfar, F, Heidari, I,. High-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension. ARYA Atheroscler. (2015) 11:21–9. 26089927.
135. Khan, A, Safdar, M, Ali Khan, MM, Khattak, KN, Anderson, RA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. (2003) 26:3215–8. 10.2337/diacare.26.12.3215, 14633804.
136. Mang, B, Wolters, M, Schmitt, B, Kelb, K, Lichtinghagen, R, Stichtenoth, DO,. Effects of a cinnamon extract on plasma glucose, hba, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest. (2006) 36:340–4. 10.1111/j.1365-2362.2006.01629.x, 16634838.
137. Blevins, SM, Leyva, MJ, Brown, J, Wright, J, Scofield, RH, Aston, CE. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care. (2007). 30:2236–7. 10.2337/dc07-0098, 17563345.
138. Vanschoonbeek, K, Thomassen, BJ, Senden, JM, Wodzig, WK, van Loon, LJ. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr. (2006) 136:977–80. 10.1093/jn/136.4.977.
139. Tang, M, Larson-Meyer, DE, Liebman, M. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr. (2008) 87:1262–7. 10.1093/ajcn/87.5.1262, 18469248.
140. Altschuler, JA, Casella, SJ, MacKenzie, TA, Curtis, KM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care. (2007) 30:813–6. 10.2337/dc06-1871, 17392542.
141. Akilen, R, Tsiami, A, Devendra, D, Robinson, N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med. (2010) 27:1159–67. 10.1111/j.1464-5491.2010.03079.x, 20854384.
142. Wainstein, J, Ganz, T, Boaz, M, Bar Dayan, Y, Dolev, E, Kerem, Z,. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food. (2012) 15:605–610. 10.1089/jmf.2011.0243, 22512698.
143. Timmers, S, Konings, E, Bilet, L, Houtkooper, RH, van de Weijer, T, Goossens, GH,. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab. (2011) 14:612–22. 10.1016/j.cmet.2011.10.002, 22055504.
144. Pérez-Jiménez, J, Neveu, V, Vos, F, Scalbert, A. Identification of the 100 richest dietary sources of polyphenols: an application of the phenol-explorer database. Eur J Clin Nutr. (2010) 64:S112–20. 10.1038/ejcn.2010.221, 21045839.
145. Ye, EQ, Chacko, SA, Chou, EL, Kugizaki, M, Liu, S. Greater whole-grain intake is associated with lower risk of type 2 diabetes, cardiovascular disease, and weight gain. J Nutr. (2012) 142:1304–13. 10.3945/jn.111.155325, 22649266.
146. Kovatcheva-Datchary, P, Nilsson, A, Akrami, R, Lee, YS, De Vadder, F, Arora, T,. Dietary fiber-induced improvement in glucose metabolism is associated with increased abundance of prevotella. Cell Metab. (2015) 22:971–82. 10.1016/j.cmet.2015.10.001, 26552345.
147. Estruch, R. Anti-inflammatory effects of the mediterranean diet: the experience of the predimed study. Proc Nutr Soc. (2010) 69:333–40. 10.1017/S0029665110001539, 20515519.
148. Salas-Salvado, J, Bullo, M, Estruch, R, Ros, E, Covas, MI, Ibarrola-Jurado, N,. Prevention of diabetes with mediterranean diets: a subgroup analysis of a randomized trial. Ann Int Med. (2014) 160:1–10. 10.7326/M13-1725, 24573661.
149. De Bock, M, Derraik, JG, Brennan, CM, Biggs, JB, Morgan, PE, Hodgkinson, SC,. Olive (Olea Europaea l.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS ONE. (2013) 8:e57622. 10.1371/journal.pone.0057622, 23516412.
150. Shiomi, Y, Nishiumi, S, Ooi, M, Hatano, N, Shinohara, M, Yoshie, T,. GCMS-based metabolomic study in mice with colitis induced by dextran sulfate sodium. Inflamm Bowel Dis. (2011) 17:2261–74. 10.1002/ibd.21616, 21287666.
151. Russell, WR, Gratz, SW, Duncan, SH, Holtrop, G, Ince, J, Scobbie, L,. High-protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. Am J Clin Nutr. (2011) 93:1062–72. 10.3945/ajcn.110.002188, 21389180.
152. De Filippis, F, Pellegrini, N, Vannini, L, Jeffery, IB, La Storia, A, Laghi, L,. High-Level Adherence to a Mediterranean Diet Beneficially Impacts the Gut Microbiota and Associated Metabolome. Gut. (2016) 65:1812–21. 10.1136/gutjnl-2015-309957, 26416813.
153. Stamler, J, Daviglus, ML, Garside, DB, Dyer, AR, Greenland, P, Neaton, JD. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. JAMA. (2000) 284:311–8. 10.1001/jama.284.3.311, 10891962.
154. Drasar, BS, Crowther, JS, Goddard, P, Hawksworth, G, Hill, MJ, Peach, S,. The relation between diet and the gut microflora in man. Proc Nutr Soc. (2007) 32:49–52. 10.1079/PNS19730014, 4791056.
155. Fava, F, Gitau, R, Griffin, BA, Gibson, GR, Tuohy, KM, Lovegrove, JA. The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population. Int J Obes. (2013) 37:216–23. 10.1038/ijo.2012.33, 22410962.
156. Ferguson, LR, De Caterina, R, Görman, U, Allayee, H, Kohlmeier, M, Prasad, C,. Guide and position of the international society of nutrigenetics/nutrigenomics on personalised nutrition: part 1 - fields of precision nutrition. J Nutrigenet Nutrigenomics. (2016) 9:12–27. 10.1159/000445350, 27169401.
157. Kaati, G, Bygren, LO, Edvinsson, S. Cardiovascular and diabetes mortality determined by nutrition during parents' and grandparents' slow growth period. Eur J Hum Genet. (2002) 10:682–8. 10.1038/sj.ejhg.5200859, 12404098.
158. Niculescu, MD. Epigenetic transgenerational inheritance: should obesity- prevention policies be reconsidered?, Synesis. (2011) 2:G18–26.
159. Thorsell, A, Nätt, D. Maternal stress and diet may influence affective behavior and stress-response in offspring via epigenetic regulation of central peptidergic function. Environ Epigenet. (2016) 2:dvw012. 10.1093/eep/dvw012, 29492293.
160. Parlee, SD, MacDougald, OA. Maternal nutrition and risk of obesity in offspring: the trojan horse of developmental plasticity. Biochim Biophys Acta. (2014) 1842:495–506. 10.1016/j.bbadis.2013.07.007, 23871838.
161. Ross, MG, Desai, M. Developmental programming of offspring obesity, adipogenesis, and appetite. Clin Obstet Gynecol. (2013) 56:529–36. 10.1097/GRF.0b013e318299c39d, 23751877.
162. Soubry, A, Schildkraut, JM, Murtha, A, Wang, F, Huang, Z, Bernal, A,. Paternal obesity is associated with IGF2hypomethylation in newborns: results from a newborn epigenetics. Study (NEST) cohort. BMC Med. (2013) 11:29. 10.1186/1741-7015-11-29, 23388414.
163. Ulrey, CL, Liu, L, Andrews, LG, Tollefsbol, TO. The impact of metabolism on DNA methylation. Hum Mol Genet. (2005) 14:R139–47. 10.1093/hmg/ddi100, 15809266.
164. Healey, GR, Murphy, R, Brough, L, Butts, CA, Coad, J. Interindividual variability in gut microbiota and host response to dietary interventions. Nutr Rev. (2017) 75:1059–80. 10.1093/nutrit/nux062, 29190368.
165. Matei, B, Salzat, J, Diguta, CF, Cornea, CP, Luta, G, Utoiu, ER,. Lactic acid bacteria strains isolated from kombucha with potential probiotic effect. Rom Biotechnol Lett. (2018) 23:13592–8. 10.26327/RBL2017.133.
166. Goanta, CM, Cirpaciu, D, Tusaliu, M, Georgescu, M, Ditu, LM, Budu, VA,. Probiotics as a therapeutic option to reduce the duration of upper respiratory tract infections in children. Rom Biotechnol Lett. (2017) 22:12329–33.
167. Mizielinska, M, Lopusiewicz, L. Encapsulation and evaluation of probiotic bacteria survival in simulated gastrointestinal conditions. Rom Biotechnol Lett. (2018) 23:13690–6.
168. Muresan, A, Sarbu, I, Pelinescu, D, Ionescu, R, Csutak, O, Stoica, I,. In vitro selection of some lactic acid bacteria strains with probiotic potential. Rom Biotechnol Lett. (2018) 23:13327–39.
169. Zamfir, M, Stefan, IR, Grosu-Tudor, SS. Influence of growth medium composition on the bacteriocin activity of some lactic acid bacteria. Rom Biotechnol Lett. (2016) 22:12126–35.
170. Yoo, JY, Kim, SS. Probiotics and prebiotics: present status and future perspectives on metabolic disorders. Nutrients. (2016) 8:173. 10.3390/nu8030173, 26999199.
171. Matsuzaki, T, Takagi, A, Ikemura, H, Matsuguchi, T, Yokokura, T. Intestinal microflora: probiotics and autoimmunity. J Nutr. (2007) 137:798S−802S. 10.1093/jn/137.3.798S, 17311978.
172. Matsuzaki, T, Yamazaki, R, Hashimoto, S, Yokokura, T. Antidiabetic effect of an oral administration of Lactobacillus Casei in a Non-Insulin Dependent Diabetes Mellitus (NIDDM) model using KK-Ay mice. Endocr J. (1997) 44:357–65. 10.1507/endocrj.44.357.
173. Tabuchi, M, Ozaki, M, Tamura, A, Yamada, N, Ishida, T, Hosoda, M,. Antidiabetic effect of lactobacillus GG in streptozotocin-induced diabetic rats. Biosci Biotechnol Biochem. (2003) 67:1421–4. 10.1271/bbb.67.1421, 12843677.
174. Yadav, H, Jain, S, Sinha, PR. Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition. (2007) 23:62–8. 10.1016/j.nut.2006.09.002, 17084593.
175. Yadav, H, Jain, S, Sinha, PR. Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin- induced diabetes in rats. J Dairy Res. (2008) 75:189–95. 10.1017/S0022029908003129, 18474136.
176. Al-Salami, H, Butt, G, Tucker, I, Skrbic, R, Mikov, M, Golocorbin-Kon, S. Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats. Arch Drug Inf. (2008) 1:35–41. 10.1111/j.1753-5174.2008.00006.x, 20157366.
177. Panwar, H, Rashmi, HM, Batish, VK, Grover, S. Probiotics as potential biotherapeutics in the management of type 2 diabetes - prospects and perspectives. Diabetes Metab Res Rev. (2013) 29:103–12. 10.1002/dmrr.2376, 23225499.
178. Ma, X, Hua, J, Li, Z. Probiotics improve high fat diet-induced hepatic steatosis and insulin resistance by increasing hepatic NKT cells. J Hepatol. (2008) 49:821–30. 10.1016/j.jhep.2008.05.025, 18674841.
179. Andersson, U, Bränning, C, Ahrné, S, Molin, G, Alenfall, J, Onning, G,. Probiotics lower plasma glucose in the high-fat fed C57BL/6 J mouse. Benef Microbes. (2010) 12:189–96. 10.3920/BM2009.0036.
180. Lu, YC, Yin, LT, Chang, WT, Huang, JS. Effect of Lactobacillus reuteri GMNL- 263 treatment on renal fibrosis in diabetic rats. J Biosci Bioeng. (2010) 110:709–15. 10.1016/j.jbiosc.2010.07.006, 20691633.
181. Manirarora, JN, Parnell, SA, Hu, YH, Kosiewich, MM, Alard, P. NOD dendritic cells stimulated with Lactobacilli preferentially produce IL-10 versus IL-12 and decrease diabetes incidence. Clin Dev Immunol. (2011) 2011:630187. 10.1155/2011/630187, 21716731.
182. Lee, E, Jung, SR, Lee, SY, Lee, NK, Paik, HD, Lim, SI. Lactobacillus plantarum strain Ln4 attenuates diet-induced obesity, insulin resistance, and changes in hepatic MRNA levels associated with glucose and lipid metabolism. Nutrients. (2018) 10:643. 10.3390/nu10050643, 29783731.
183. Rossi, M, Amaretti, A, Raimondi, S. Folate production by probiotic bacteria. Nutrients. (2011) 3:118–34. 10.3390/nu3010118, 22254078.
184. Ejtahed, HS, Mohtadi-Nia, J, Homayouni-Rad, A, Niafar, M, Asghari-Jafarabadi, M, Mofid, V. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 mellitus. J Dairy Sci. (2011) 94:3288–94. 10.3168/jds.2010-4128, 21700013.
185. Ejtahed, HS, Mohtadi-Nia, J, Homayouni-Rad, A, Niafar, M, Asghari-Jafarabadi, M, Mofid, V. Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition. (2012) 28:539–43. 10.1016/j.nut.2011.08.013, 22129852.
186. Tong, X, Xu, J, Lian, F, Yu, X, Zhao, Y, Xu, L,. Structural alteration of gut microbiota during the amelioration of human type 2 diabetes with hyperlipidemia by metformin and a traditional chinese herbal formula: a multicenter, randomized, open label clinical trial. MBio. (2018) 9:e02392–117. 10.1128/mBio.02392-17, 29789365.
187. Luoto, R, Laitinen, K, Nermes, M, Isolauri, E. Impact of maternal probiotic-supplemented dietary counseling during pregnancy on colostrum adiponectin concentration: a prospective, randomized, placebo-controlled study. Early Hum Dev. (2012) 88:339–44. 10.1016/j.earlhumdev.2011.09.006, 21945174.
188. Kijmanawat, A, Panburana, P, Reutrakul, S, Tangshewinsirikul, C. The effects of probiotic supplements on insulin resistance in gestational diabetes mellitus: a double-blind randomized controlled trial. J Diabetes Investig. (2019) 10:163–70. 10.1111/jdi.12863, 29781243.
189. Raygan, F, Rezavandi, Z, Bahmani, F, Ostadmohammadi, V, Mansournia, MA, Tajabadi-Ebrahimi, M,. The efects of probiotic supplementation on metabolic status in type 2 diabetic patients with coronary heart disease. Diabetol Metab Syndr. (2018) 10:51. 10.1186/s13098-018-0353-2, 29946368.
190. Sabico, S, Al-Mashharawi, A, Al-Daghri, NM, Wani, K, Amer, OE, Hussain, DS,. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: a randomized, double-blind, placebo-controlled trial. Clin Nutr. (2018) 18:31351–7. 10.1016/j.clnu.2018.08.009.
191. Zugravu, CA, Baciu, A, Patrascu, D, Tarcea, M, Stoian, A. Depression and diabetes: are there any consequences on self-care?, Eur J Public Health. (2012) 22:272.
192. Raygan, F, Ostadmohammadi, V, Bahmani, F, Asemi, Z. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: a randomized, double-blind, placebo-controlled trial. Prog Neuropsychopharmacol Biol Psychiatry. (2018) 84:50–5. 10.1016/j.pnpbp.2018.02.007, 29432877.
193. Andreasen, AS, Larsen, N, Pedersen-Skovsgaard, T, Berg, RM, Møller, K, Svendsen, KD,. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr. (2010) 10412:1831–8. 10.1017/S0007114510002874.
194. Kobyliak, N, Falalyeyeva, T, Mykhalchyshyn, G, Kyriienko, D, Komissarenko, I. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: randomized clinical trial. Diabetes Metab Syndr. (2018) 12:617–24. 10.1016/j.dsx.2018.04.015, 29661605.
195. Kim, M, Shin, HK. The water-soluble extract of chicory influences serum and liver lipid concentrations, cecal short-chain fatty acid concentrations and fecal lipid excretion in rats. J Nutr. (1998) 128:1731–6. 10.1093/jn/128.10.1731, 9772143.
196. Gibson, GR, Roberfroid, M. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. (1995) 125:1401–12. 10.1093/jn/125.6.1401, 7782892.
197. Causey, JL, Feirtag, JM, Gallaher, DD, Tungland, BC, Slavin, JL. Effects of dietary inulin on serum lipids, blood glucose and the gastrointestinal, environment in hypercholesterolemic men. Nutr Res. (2000) 20:191–201. 10.1016/S0271-5317(99)00152-9.
198. Brighenti, F, Casiraghi, MC, Canzi, E, Ferrari, A. Effect of consumption of a ready-to-eat breakfast cereal containing inulin on the intestinal milieu and blood lipids in healthy male volunteers. Eur J Clin Nutr. (1999) 53:726–33. 10.1038/sj.ejcn.1600841, 10509770.
199. Dikeman, CL, Murphy, MR, Fahey, GC, Jr. Dietary fibers affect viscosity of solutions and simulated human gastric and small intestinal digesta. J Nutr. (2006) 136:913–9. 10.1093/jn/136.4.913, 16549450.
200. Gibson, GR, Probert, HM, Loo, JV, Rastall, RA, Roberfroid, MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev. (2004) 17:259–75. 10.1079/NRR200479, 19079930.
201. Hald, S, Schioldan, AG, Moore, ME, Dige, A, Lærke, HN, Agnholt, J,. Effects of arabinoxylan and resistant starch on intestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. PLoS ONE. (2016) 11:e0159223. 10.1371/journal.pone.0159223, 27434092.
202. Moroti, C, Souza Magri, LF, de Rezende Costa, M, Cavallini, DC, Sivieri, K. Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis. (2012) 11:29. 10.1186/1476-511X-11-29, 22356933.